Recombinant antibodies against Iranian cobra venom as a new emerging therapy by phage display technology

BACKGROUND: The production of antivenom from immunized animals is an established treatment for snakebites; however, antibody phage display technology may have the capacity to delivery results more quickly and with a better match to local need. Naja oxiana, the Iranian cobra, is a medically important...

Descripción completa

Detalles Bibliográficos
Autores principales: Nazari, Ali, Samianifard, Maedeh, Rabie, Hadi, Mirakabadi, Abbas Zare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Estudos de Venenos e Animais Peçonhentos 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346683/
https://www.ncbi.nlm.nih.gov/pubmed/32695146
http://dx.doi.org/10.1590/1678-9199-JVATITD-2019-0099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346683/
https://www.ncbi.nlm.nih.gov/pubmed/32695146
http://dx.doi.org/10.1590/1678-9199-JVATITD-2019-0099

Ejemplares similares